Brief: Transgene Appoints Alessandro Riva As Chairman And CEO
May 5 (Reuters) - Transgene SA TRNG.PA :
* BOARD HAS APPOINTED DR ALESSANDRO RIVA, MD, AS COMPANY'S
NEW
CHAIRMAN AND CEO
* ALESSANDRO RIVA, WHO HAS BEEN CHAIRMAN OF TRANSGENE'S
BOARD OF
DIRECTORS SINCE MAY 2022, WILL REPLACE HEDI BEN BRAHIM,
EFFECTIVE JUNE 1ST, 2023
Source text for Eikon: ID:nBw3qZtDJa
Further company coverage: TRNG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;))
Recent news on Transgene SA
See all newsFrance's Transgene H1 operating income falls on lower tax credit
Transgene jumps 20% on positive cancer vaccine data in early trial
Brief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs